Nucletron releases update for Oncentra Treatment Planning; FDA OKs Simulix Evolution

Nucletron B.V. has announced the clinical release of Oncentra Treatment Planning version 1.3.

Oncentra Treatment Planning is a PC-based planning system that features art image contouring, registration, fusion tools, dose calculation functionality and DICOM connectivity. The latest release offers archiving capabilities to any DICOM Archive supporting DICOM RT objects.

Nucletron also has received FDA 510(k) clearance for Simulix Evolution, an advanced digital technology for radiation treatment planning, simulation and verification that improves the quality of radiation cancer therapy

Simulix is available as a complete system, as well as an upgrade for existing Simulix systems. Simulix Evolution has undergone successful clinical testing in Europe and the United States.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup